Servier
France cleans up regulation – and restricts pharma role
July 14, 2011Research and Development, Sales and Marketing France, Mediator, Servier, pharmacovigilance, research and development news
France has unveiled sweeping changes to how it regulates prescription medicines following the scandal surrounding Servier’s Médiator. Health minister Xavier …
UK suing Servier over alleged generic blocking
June 7, 2011Sales and Marketing Peridopril, Servier, generics
The UK government is taking Servier to court for allegedly blocking generic versions of its blood pressure drug Perindopril from …
French pharma firm denies drug risk cover up
May 10, 2011Sales and Marketing Mediator, Servier, drug safety
France’s second biggest pharma firm Servier has denied allegations it concealed risks associated with its diabetes drug Mediator (benfluorex). Research …
Pressure mounts on Servier over Mediator controversy
February 3, 2011Sales and Marketing France, G5, Mediator, Servier, benfluorex
Dr Jacques Servier has stepped down from his role as head of a French pharma industry association as controversy grows …
Decision on osteoporosis drug Protelos unchanged, says NICE
January 27, 2011Sales and Marketing NICE, Protelos, Servier, osteoporotic fractures, strontium ranelate
NICE has published updated final guidance on preventing osteoporotic fractures following a reconsideration of the use of Servier’s Protelos. The …
Servier’s Mediator provokes French drug safety controversy
January 12, 2011Sales and Marketing AFSSAPS, France, Mediator, Servier, benfluorex, drug safety
Serious questions are being asked about drug safety monitoring in France in connection with Servier’s Mediator (benfluorex) which was withdrawn …
Digital Pharma: Pharma iPhone app update
October 15, 2010Medical Communications Astellas, Boehringer, Digital Pharma blog, GlaxoSmithKline, Lundbeck, Menarini, Nycomed, Pfizer, Servier, Teva, app, iphone
The ranks of pharma iPhone apps are increasing all the time and recent months have seen new additions from Teva, …
Servier fails to overturn NICE osteoporotic guidance
February 2, 2010Sales and Marketing NICE, Servier, osteoporosis
Servier’s challenge to NICE guidance on preventing osteoporotic fractures has proved unsuccessful, with the watchdog’s original decision still standing. This …
Manufacturing news in brief
December 1, 2009Manufacturing and Production Aurobindo, Servier
Our periodic round-up of developments in the pharmaceutical manufacturing sector reveals a crop of facility news, with capital investments at …
Servier signs drug discovery deal with Vernalis
May 7, 2009Research and Development, Sales and Marketing Servier, Vernalis
Servier, France's largest privately-owned pharma company, has signed a new three-year drug discovery deal with Vernalis focused on oncology. UK …
Servier claims victory over NICE in osteoporosis
February 19, 2009Research and Development, Sales and Marketing NICE, Servier
Servier has claimed victory in the first round of its legal battle against NICE's guidelines on osteoporosis.A judicial review requested …
